Prevalence of metabolic syndrome among Malaysians using the International Diabetes Federation, National Cholesterol Education Program and modified World Health Organization definitions

Malaysian Journal of Nutrition

Volumn 14, Issue 1, 2008, Pages 65-77

  Tan, Bee Ying ^a   Kantilal, Haresh Kumar ^a   Singh, Rajbans ^b  

^a UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

^b Pantai Medical Centre   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57349112434     PISSN: 1394035X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Adams RJ, Appleton S, Wilson DH, Taylor AW, Grande ED, Chittleborough C, Gill T & Ruffin R (2005). Population comparision of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care 28: 2777-2779.
2. Alberti KG & Zimmet PZ (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus procisional report of a WHO consultation. Diabetes Medicine 15: 539-553.
3. Altman DG (1991). Some Practical Statistics for Medical Research. 1st ed. Champan and Hall. 404 pp.
4. Balkau B & Charles MA (1999). Comment of the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetes Medicine 16: 442-443.
5. Choi KY, Kim SM, Kim YE, Choi DS, Baik SY, Lee J (2007). Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Metabolism Clinical and Experiments 56: 552-558.
6. Desroches, S & Lamarche, B (2007). The evolving definitions and increasing prevalence of the metabolic syndrome. Applied Physiology, Nutrition & Metabolism 32: 23-32.
7. Eckel RH, Grundy SM & Zimmet PZ (2005). The metabolic syndrome. Lancet 365: 1415-1428.
8. Ford ES (2005). Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the United States. Diabetes Care 28: 2745-2749.
9. Glassock RJ (2004). The rising tide of end-stage renal disease: what can be done? Clinical and Experimental Nephrology 8: 291-296.
10. Grundy SM (2006). Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. Journal of the American College of Cardiology 47: 1093-1100.
11. Grundy SM, Pasternak R, Greenland P, Smith Jr S & Fuster V (1999). AHA/ACC scientific statement: assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for health care professionals from the American Heart Association and the American College of Cardiology. Circulation 100: 1481-1492.
12. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA & Costa F (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752.
13. Guerrero-Romero F & Rodriguez-Moran M (2005). Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization Definitions. Diabetes Care 28: 2588-2589.
14. Hansen BC (1999). The metabolic syndrome X. Annals of the New York Academy of Science 892: 1-24.
15. Hu FB, Stampfer MJ, Manson JE, Grodstein F, Colditz GA, Speizer FE & Willett WC (2000). Trends in the incidence of coronary heart disease and changes in the diet and life-style in women. New England Journal of Medicine 343: 530-537.
16. Ibrahim H & Yusoff MM (2007). Plant-based ethnic remedies for hypertension from Malaysia. Thieme, DOI: 10.1055/S-2007-987422.
17. Ismail MN, Chee SS, Nawawi H, Yusoff K, Lim TO & James PT (2002). Obesity in Malaysia. Obesity Reviews 3(3): 203-208.
18. Johnson LW & Weinstock RS (2006) The metabolic syndrome: concepts and controversy. Mayo Clinic Proceedings 81(12): 1615-1620.
19. Ko GTC, Cockram CS, Chow CC, Yeung VTF, Chan WB, So WY, Chan, N.N. & Chan JCN (2006). Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese. Diabetes Research Clinical Practice. 73: 58-64.
20. Kyung MC, Seon MK, Yeong EK, Dong SC, Sei HB & Lee JY (2006). Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Metabolism Clinical and Experimental 56: 552-558.
21. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT & Lakka TA (2002). Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in prospective cohort study. American Journal of Epidemiology 156 (11): 1070-1077.
22. Lee WY, Park JS, Noh SY, Rhee EJ, Kim SW & Zimmet PZ (2004). Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Research Clinical Practice 65: 143-149.
23. Lim TO, Ding LM, Goh BL, Zaki M & Suleiman AB (2000). Distribution of blood pressure in a national sample of Malaysian adults. Medical Journal of Malaysia 55: 90-107.
24. National Cholesterol Education Program (NCEP) (2001). Executive summary of the third report of the National Cholesterol Education Program Expert Panel on Detection, Evalution, and Treatment of Hight Blood Cholesterol in Adults (Adults Treatment Panel III). Journal of the American Medical Association 285: 2486-2497.
25. Reaven GM (1988). Banting lecture 1988: role of insulin resistance in human disease. Diabetes 37: 1595-1607.
26. Samad MI, Ismail F, Salwa A, Daud NA, Omar ZA & Ooyub S (2002). National programme for the prevention and control of hypertension. NCD Malaysia 1(2): 16-22.
27. Solymoss BC, Bourassa MG, Lesperance J, Levesque S, Marcil M, Varga S & Campeau L (2003). Incidence and clinical characteristics of the metabolic syndrome in patients with coronary heart disease. Coronary Artery Disease 14: 207-212.
28. Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, Katayama S, Saito Y, Ito H, Ohashi Y, Akanuma Y & Yamada N (2005). Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetes patients? Diabetes Care 28(6): 1463-1471.
29. Steering Committee (2000). The Asia-Pacific Perspective: Redefining Obesity and its treatment. Melbourne, Australia. International Diabetes Institute.
30. Undurti ND (2002). Is metabolic syndrome X an inflammatory condition? Society for Experimental Biology and Medicine, pp. 989-997.
31. World Health Organization (WHO) (1999). Definitions, diagnosis and classification of diabetes mellitus and its complication. Report of a WHO consultation. Geneva, Switzerland: Department of Non-communicate Disease Surveillance.
32. World Health Organization (WHO) Expert Consultation (2004). Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-63.
33. Zabetian A, Hadaegh F & Azizi F (2007). Prevalence of metabolic syndrome in Iranian adult population concordance between the IDF with the ATP III and the WHO definitions. Diabetes Research and Clinical Practice 77: 215-257.
34. Zimmet PZ, Alberti G, & Shaw J (2005). A new IDF worldwide definition of the metabolic syndrome: the rationale and the results. Diabetes Voice 50(3): 31-33.